B. Douvry

发表

Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study

J. Jais, D. Lebeaux, N. Mueller, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Airway microbiota signals anabolic and catabolic remodeling in the transplanted lung

C. Auffray, R. Slama, J. Vincent, 2017, The Journal of allergy and clinical immunology.

T Cells Promote Bronchial Epithelial Cell Secretion of Matrix Metalloproteinase‐9 via a C‐C Chemokine Receptor Type 2 Pathway: Implications for Chronic Lung Allograft Dysfunction

J. Vincent, Y. Castier, A. Didier, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Blood CD9+ B cell, a biomarker of bronchiolitis obliterans syndrome after lung transplantation

R. Slama, Y. Castier, J. Pellet, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

High Emergency Lung Transplantation: dramatic decrease of waiting list death rate without relevant higher post‐transplant mortality

M. Stern, D. Grenet, E. Cuquemelle, 2015, Transplant international : official journal of the European Society for Organ Transplantation.

Antibody‐Mediated Rejection in Lung Transplantation: Clinical Outcomes and Donor‐Specific Antibody Characteristics

Kimberly A. Thomas, R. Spreafico, A. Roux, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Tobacco-associated pulmonary vascular dysfunction in smokers: role of the ET-1 pathway.

P. Devillier, A. Cazes, C. Delclaux, 2011, American journal of physiology. Lung cellular and molecular physiology.

CALL FOR PAPERS Cigarette Smoke-Induced Lung Endothelial and Alveolar

P. Devillier, A. Cazes, C. Delclaux, 2011 .

Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis.

S. Leroy, P. Burgel, J. Paillasseur, 2022, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation

Kimberly A. Thomas, M. Rossetti, M. Stern, 2017, Front. Med..

Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study.

J. Jais, D. Lebeaux, S. Van Laecke, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Posaconazole Tablets in Real-Life Lung Transplantation: Impact on Exposure, Drug-Drug Interactions, and Drug Management in Lung Transplant Patients, Including Those with Cystic Fibrosis

L. Lécuyer, R. Guillemain, D. Grenet, 2018, Antimicrobial Agents and Chemotherapy.

The French compassionate programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant

P. Burgel, I. Durieu, I. Sermet-Gaudelus, 2023, European Respiratory Journal.

Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN)

R. Epaud, D. Grenet, G. Thouvenin, 2022, Frontiers in Public Health.

Lung transplantation for scleroderma lung disease: An international, multicenter, observational cohort study.

L. Savale, M. Reynaud‐Gaubert, L. Godinas, 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Outcome Of Patients With Interstitial Lung Disease Admitted To An Intensive Care Unit

E. Guérot, O. Sanchez, D. Wermert, 2012, ATS 2012.

Management of early infection with Pseudomonas aeruginosa in adults with bronchiectasis: A survey of French pulmonologist's practices.

P. Burgel, Anne Bergeron, B. Maître, 2021, Respiratory medicine and research.

[Follow-up strategies for lung transplant recipients in France].

N. Bautin, N. Bautin, T. Dégot, 2023, Revue des maladies respiratoires.

Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription

P. Reix, A. Guillaumot, I. Sermet-Gaudelus, 2023, European Respiratory Journal.